Navigation Links
NaphCare, Inc. Continues Partnership with Wende and Fishkill Correctional Facilities
Date:12/15/2012

Birmingham, AL (PRWEB) December 15, 2012

In total, NaphCare has been a partner with the NYDOCCS for nearly 20 years. Each partnership began with the start of each facility; Fishkill in 1995 and Wende in 2000. Both facilities are part of the NYDOCCS, together housing an average population of 2600 inmates.

“Continuing a successful partnership with the NYDOCCS is exemplary of all the devoted, hard-working professionals on both NaphCare and NYDOCCS’s team that serve at the Fishkill and Wende facilities,” says Rick Apollo, Vice-President of Ancillary Services. “Many team members have been with NaphCare since the beginning of these agreements and it is that type of commitment we can attribute our success. We value the relationships and look forward to continuing our philosophy of providing excellent dialysis services.”

NaphCare, Inc., is the leading provider of on-site correctional dialysis services and has provided nephrology services to county, state, and federal correctional facilities across the country. Services include hemodialysis, peritoneal dialysis, inpatient management, and nephrology consultations.

About NaphCare
Since 1989, NaphCare has been managing a full range of healthcare programs for correctional facilities throughout the country, providing quality, proactive care through creative solutions and innovative technology.

Read the full story at http://www.prweb.com/releases/2012/12/prweb10238494.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Secondhand smoke continues to vex children with asthma
2. U.S. Teen Pregnancy Rate Continues to Fall
3. FlowVision Continues to Add to Its Intellectual Property Portfolio
4. Use of retail medical clinics continues to grow, study finds
5. U.S. Preterm Birth Rate Continues to Drop: Report
6. Cavern Technologies Kansas City Data Center Continues Rapid Growth with Latest Data Center Expansion
7. University of Houston Graduate College of Social Work announces partnership with MD Anderson
8. Partnership provides inclusive workout
9. Global Cassava Partnership for the 21st Century (GCP21)
10. FDA clears test developed in partnership with VCU researcher
11. ACP-New York State Chapter partnership results in patient safety organization recognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 29, 2017 , ... An inventor from Raynham, Mass., knows ... in conjunction with my braces always rubbed against the inside of my cheeks, ... this problem." The O.B.S. was the result of his brainstorming. , This patent-pending ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an ... 20, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , Home health and hospice companies are still popular targets for healthcare investors. ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... in many scientific laboratories. The assembly protocols involve many repetitive steps and often ... for automation, which enables the high-throughput needed, and results in a lower error ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... CA (PRWEB) , ... March 29, 2017 , ... Hamlin ... Northridge , is now offering laser dental treatments. Dental lasers are safe and effective ... dentistry expands patients’ options and can improve the overall quality of care. , Dr. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... VICTORIA and TORONTO , ... Canada,s leading full service medical device development ... Group, the visionary Toronto -based medical ... entity will better serve medtech companies throughout ... increased resources and experienced medical device talent spanning the ...
(Date:3/28/2017)... and TEL AVIV, Israel , March 28, ... in Israel . This new business entity, Emosis ... mostly dedicated to research and development of novel assays complementing the ... also, when relevant, locally support commercialization and sales development of Emosis ... This strategic ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: